Research_医药人-Daniel
26-06-29 11:33 微博认证:财经博主

Foresite 关于Candid 的故事:

We atForesite Capitalare still buzzing from yesterday’s announcement and wanted to once again congratulateCandid Therapeuticson their acquisition byUCBfor $2B+.

可以去他们官网看原文。老外的资金组合效率,我们是前端早研创新药输出。ken company

发布于 上海